Raja Kumaraguru
Stock Analyst at Roth MKM
(n/a)
# 4,579
Out of 4,944 analysts
5
Total ratings
n/a
Success rate
-43.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Raja Kumaraguru
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAIN Rain Enhancement Technologies Holdco | Downgrades: Neutral | $1.2 | $3.40 | -64.71% | 1 | May 30, 2023 | |
| NLSP NLS Pharmaceutics AG | Initiates: Buy | $480 | $2.24 | +21,328.57% | 1 | Mar 12, 2021 | |
| CNSP CNS Pharmaceuticals | Initiates: Buy | $9,000,000 | $6.32 | +142,404,963.29% | 1 | Feb 2, 2021 | |
| FBRX Forte Biosciences | Initiates: Buy | $2,250 | $11.26 | +19,891.12% | 1 | Aug 28, 2020 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $210 | $32.50 | +546.15% | 1 | Feb 19, 2020 |
Rain Enhancement Technologies Holdco
May 30, 2023
Downgrades: Neutral
Price Target: $1.2
Current: $3.40
Upside: -64.71%
NLS Pharmaceutics AG
Mar 12, 2021
Initiates: Buy
Price Target: $480
Current: $2.24
Upside: +21,328.57%
CNS Pharmaceuticals
Feb 2, 2021
Initiates: Buy
Price Target: $9,000,000
Current: $6.32
Upside: +142,404,963.29%
Forte Biosciences
Aug 28, 2020
Initiates: Buy
Price Target: $2,250
Current: $11.26
Upside: +19,891.12%
Monopar Therapeutics
Feb 19, 2020
Initiates: Buy
Price Target: $210
Current: $32.50
Upside: +546.15%